Literature DB >> 19442839

Surround optical fiber immunoassay (SOFIA): an ultra-sensitive assay for prion protein detection.

Binggong Chang1, Perry Gray, Martin Piltch, Marie S Bulgin, Sharon Sorensen-Melson, Michael W Miller, Paul Davies, David R Brown, Daniel R Coughlin, Richard Rubenstein.   

Abstract

We describe the development of a new technology (SOFIA) and demonstrate its utility by establishing a sensitive and specific assay for PrP(Sc). SOFIA is a surround optical fiber immunoassay which is comprised of a set of specific monoclonal antibodies and comprehensive capture of high energy fluorescence emission. In its current format, this system is capable of detecting less than 10 attogram (ag) of hamster, sheep and deer recombinant PrP. Approximately 10 ag of PrP(Sc) from 263 K-infected hamster brains can be detected with similar lower limits of PrP(Sc) detection from the brains of scrapie-infected sheep and deer infected with chronic wasting disease. These detection limits allow protease treated and untreated material to be diluted beyond the point where PrP(C), non-specific proteins or other extraneous material may interfere with PrP(Sc) signal detection and/or specificity. This not only eliminates the issue of specificity of PrP(Sc) detection but also increases sensitivity since the possibility of partial PrP(Sc) proteolysis is no longer a concern. SOFIA will likely lead to early antemortem detection of transmissible encephalopathies and is also amenable for use with additional target amplification protocols. SOFIA represents a sensitive means for detecting specific proteins involved in disease pathogenesis and/or diagnosis that extends beyond the scope of the transmissible spongiform encephalopathies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19442839     DOI: 10.1016/j.jviromet.2009.02.019

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  14 in total

Review 1.  New generation QuIC assays for prion seeding activity.

Authors:  Christina D Orrù; Jason M Wilham; Sarah Vascellari; Andrew G Hughson; Byron Caughey
Journal:  Prion       Date:  2012-04-01       Impact factor: 3.931

Review 2.  Quantum dots and prion proteins: is this a new challenge for neurodegenerative diseases imaging?

Authors:  Pavlina Sobrova; Iva Blazkova; Jana Chomoucka; Jana Drbohlavova; Marketa Vaculovicova; Pavel Kopel; Jaromir Hubalek; Rene Kizek; Vojtech Adam
Journal:  Prion       Date:  2013-09-20       Impact factor: 3.931

3.  Role of CD40 in prion disease and the immune response to recombinant PrP.

Authors:  Richard Rubenstein; Allen Chiu; Binggong Chang; Thomas Wisniewski
Journal:  J Neuroimmunol       Date:  2013-02-16       Impact factor: 3.478

4.  Design, implementation, and interpretation of amplification studies for prion detection.

Authors:  Nicholas J Haley; Jürgen A Richt; Kristen A Davenport; Davin M Henderson; Edward A Hoover; Matteo Manca; Byron Caughey; Douglas Marthaler; Jason Bartz; Sabine Gilch
Journal:  Prion       Date:  2018-03-09       Impact factor: 3.931

5.  Prion disease detection, PMCA kinetics, and IgG in urine from sheep naturally/experimentally infected with scrapie and deer with preclinical/clinical chronic wasting disease.

Authors:  Richard Rubenstein; Binggong Chang; Perry Gray; Martin Piltch; Marie S Bulgin; Sharon Sorensen-Melson; Michael W Miller
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

Review 6.  Recent developments in emerging microimmunoassays.

Authors:  Christine F Woolley; Mark A Hayes
Journal:  Bioanalysis       Date:  2013-01       Impact factor: 2.681

7.  A novel, ultrasensitive assay for tau: potential for assessing traumatic brain injury in tissues and biofluids.

Authors:  Richard Rubenstein; Binggong Chang; Peter Davies; Amy K Wagner; Claudia S Robertson; Kevin K W Wang
Journal:  J Neurotrauma       Date:  2014-12-23       Impact factor: 5.269

8.  Plasma Anti-Glial Fibrillary Acidic Protein Autoantibody Levels during the Acute and Chronic Phases of Traumatic Brain Injury: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot Study.

Authors:  Kevin K W Wang; Zhihui Yang; John K Yue; Zhiqun Zhang; Ethan A Winkler; Ava M Puccio; Ramon Diaz-Arrastia; Hester F Lingsma; Esther L Yuh; Pratik Mukherjee; Alex B Valadka; Wayne A Gordon; David O Okonkwo; Geoffrey T Manley; Shelly R Cooper; Kristen Dams-O'Connor; Allison J Hricik; Tomoo Inoue; Andrew I R Maas; David K Menon; David M Schnyer; Tuhin K Sinha; Mary J Vassar
Journal:  J Neurotrauma       Date:  2016-02-01       Impact factor: 5.269

9.  Prion disease blood test using immunoprecipitation and improved quaking-induced conversion.

Authors:  Christina D Orrú; Jason M Wilham; Lynne D Raymond; Franziska Kuhn; Björn Schroeder; Alex J Raeber; Byron Caughey
Journal:  MBio       Date:  2011-05-10       Impact factor: 7.867

Review 10.  TSE diagnostics: recent advances in immunoassaying prions.

Authors:  Anja Lukan; Tanja Vranac; Vladka Curin Šerbec
Journal:  Clin Dev Immunol       Date:  2013-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.